|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006826,
umls-concept:C0015560,
umls-concept:C0026882,
umls-concept:C0029939,
umls-concept:C0030797,
umls-concept:C0033105,
umls-concept:C0043210,
umls-concept:C0079419,
umls-concept:C0440743,
umls-concept:C1519316,
umls-concept:C1709634
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-5-5
|
|
pubmed:abstractText |
Early serous carcinomas predominate in the fimbria of women with BRCA mutations (BRCA+). An entity in non-neoplastic mucosa sharing several properties of early serous carcinomas--the "p53 signature"--has been described in the distal fallopian tube and proposed as a precursor to serous carcinomas. This study compared the prevalence of p53 signatures in ovarian cortical inclusion cysts (CICs) and fallopian tubes from BRCA+ women and explored their relationship.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-10526284,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-10918170,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-11389050,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-11745677,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-14574155,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-14668547,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-14669279,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-15108799,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-15169974,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-15279782,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-15467531,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-15880741,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-15949437,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-16051332,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-16095676,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-16137750,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-16319259,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-16552174,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-17255760,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-17673924,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-17761984,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-18455635,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-7825587,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-8137211,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18342932-8847068
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1095-6859
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
109
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
168-73
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18342932-Adnexa Uteri,
pubmed-meshheading:18342932-Adult,
pubmed-meshheading:18342932-Aged,
pubmed-meshheading:18342932-Carcinoma,
pubmed-meshheading:18342932-Cysts,
pubmed-meshheading:18342932-DNA Damage,
pubmed-meshheading:18342932-Fallopian Tubes,
pubmed-meshheading:18342932-Female,
pubmed-meshheading:18342932-Genes, BRCA1,
pubmed-meshheading:18342932-Genes, BRCA2,
pubmed-meshheading:18342932-Genes, Tumor Suppressor,
pubmed-meshheading:18342932-Histones,
pubmed-meshheading:18342932-Humans,
pubmed-meshheading:18342932-Middle Aged,
pubmed-meshheading:18342932-Mutation,
pubmed-meshheading:18342932-Ovarian Diseases,
pubmed-meshheading:18342932-Ovary,
pubmed-meshheading:18342932-Pelvic Neoplasms,
pubmed-meshheading:18342932-Precancerous Conditions,
pubmed-meshheading:18342932-Tumor Suppressor Protein p53
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations.
|
|
pubmed:affiliation |
The Division of Women's and Perinatal Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
